Liminatus Pharma, Inc. (LIMN)
0.178
0.00 (0.00%)
USD |
NASDAQ |
May 18, 12:45
Liminatus Pharma Price : 0.178 for May 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Oruka Therapeutics, Inc. | 58.68 |
| MapLight Therapeutics, Inc. | 26.48 |
| Kailera Therapeutics, Inc. | 20.07 |
| Veracyte, Inc. | 40.76 |
| Insight Molecular Diagnostics, Inc. | 5.99 |
Price Related Metrics
| PEG Ratio | -0.0016 |
| Earnings Yield | -222.2% |
| Market Cap | 7.988M |
| PEGY Ratio | -0.0016 |